agilon health, inc. (NYSE:AGL – Get Free Report) hit a new 52-week low on Thursday after Citigroup lowered their price target on the stock from $2.50 to $1.75. Citigroup currently has a sell rating on the stock. agilon health traded as low as $1.75 and last traded at $1.77, with a volume of 249680 shares. The stock had previously closed at $1.88.
Several other research firms have also issued reports on AGL. Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Monday. TD Cowen dropped their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday. Benchmark reiterated a “buy” rating and issued a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $6.38.
Check Out Our Latest Research Report on AGL
Insider Activity
Institutional Investors Weigh In On agilon health
Hedge funds have recently added to or reduced their stakes in the business. J.Safra Asset Management Corp lifted its stake in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. City State Bank bought a new position in shares of agilon health during the 3rd quarter worth approximately $52,000. CWM LLC boosted its holdings in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC acquired a new stake in shares of agilon health during the 2nd quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC bought a new stake in shares of agilon health in the 1st quarter valued at $65,000.
agilon health Stock Down 6.1 %
The company has a market cap of $727.22 million, a price-to-earnings ratio of -2.01 and a beta of 0.60. The stock’s 50-day moving average is $3.14 and its 200-day moving average is $4.90. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.
agilon health (NYSE:AGL – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the previous year, the company posted ($0.06) EPS. On average, analysts anticipate that agilon health, inc. will post -0.35 earnings per share for the current fiscal year.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
- Five stocks we like better than agilon health
- How to Use Stock Screeners to Find Stocks
- Top 3 R&D-Driven Stocks Showing Strong Profit and Momentum
- 3 Best Fintech Stocks for a Portfolio Boost
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- What Are Dividend Contenders? Investing in Dividend Contenders
- Tariff Troubles: 3 Stocks Planning Higher Prices
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.